FDA.reportPublic FDA data

dapagliflozin / saxagliptin

RxCUI
1727500
RxNorm name
dapagliflozin / saxagliptin
Term type
MIN
Status
Active
Updated
2026-10-21 00:30:56

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
012016
Active start
072017
Multiple ingredient
YES
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
dapagliflozin1488564
saxagliptin857974

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRdapagliflozin / sAXagliptin1NAMES
RxNorm Namedapagliflozin / saxagliptin1NAMES
TTYMIN1ATTRIBUTES
RxCUI17275001CODES
MMSL_CODEGNd085311CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA10BDCombinations of oral blood glucose lowering drugsATC1-4dapagliflozin / saxagliptin
ATCA10BHDipeptidyl peptidase 4 (DPP-4) inhibitorsATC1-4saxagliptin
ATCA10BKSodium-glucose co-transporter 2 (SGLT2) inhibitorsATC1-4dapagliflozin
FDASPLN0000187059Sodium-Glucose Cotransporter 2 InhibitorEPChas_epcdapagliflozin
FDASPLN0000187058Sodium-Glucose Transporter 2 InhibitorsMOAhas_moadapagliflozin
MEDRTD000218AdamantaneCHEMhas_ingredientsaxagliptin
MEDRTD001559Benzhydryl CompoundsCHEMhas_ingredientdapagliflozin
MEDRTD004151DipeptidesCHEMhas_ingredientsaxagliptin
MEDRTD005960GlucosidesCHEMhas_ingredientdapagliflozin
MEDRTD003924Diabetes Mellitus, Type 2DISEASEmay_treatdapagliflozin
MEDRTD003924Diabetes Mellitus, Type 2DISEASEmay_treatsaxagliptin
MEDRTD004342Drug HypersensitivityDISEASEci_withsaxagliptin
MEDRTD006333Heart FailureDISEASEmay_treatdapagliflozin
MEDRTN0000175912Dipeptidyl Peptidase 4 InhibitorsMOAhas_moasaxagliptin
MEDRTN0000187058Sodium-Glucose Transporter 2 InhibitorsMOAhas_moadapagliflozin
MEDRTN0000008644Decreased Glucagon SecretionPEhas_pesaxagliptin
MEDRTN0000175650Decreased Sympathetic ActivityPEhas_pedapagliflozin
MEDRTN0000009360Increased Insulin SecretionPEhas_pesaxagliptin
MEDRTN0000009556Increased Renal Organic Ion ExcretionPEhas_pedapagliflozin
MEDRTN0000009830Renal Ion Transport AlterationPEhas_pedapagliflozin

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESRXNAV_HUMAN_DRUGUS
CODESATCA10BD21
CODESSNOMEDCT1303126003
CODESVUID4037067
NAMESTallman Synonymdapagliflozin / sAXagliptin
SOURCESSourceAnatomical Therapeutic Chemical
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File